132 related articles for article (PubMed ID: 12904326)
1. Surfactant protein profile of pulmonary surfactant in premature infants.
Ballard PL; Merrill JD; Godinez RI; Godinez MH; Truog WE; Ballard RA
Am J Respir Crit Care Med; 2003 Nov; 168(9):1123-8. PubMed ID: 12904326
[TBL] [Abstract][Full Text] [Related]
2. Dysfunction of pulmonary surfactant in chronically ventilated premature infants.
Merrill JD; Ballard RA; Cnaan A; Hibbs AM; Godinez RI; Godinez MH; Truog WE; Ballard PL
Pediatr Res; 2004 Dec; 56(6):918-26. PubMed ID: 15496605
[TBL] [Abstract][Full Text] [Related]
3. Partial deficiency of surfactant protein B in an infant with chronic lung disease.
Ballard PL; Nogee LM; Beers MF; Ballard RA; Planer BC; Polk L; deMello DE; Moxley MA; Longmore WJ
Pediatrics; 1995 Dec; 96(6):1046-52. PubMed ID: 7491219
[TBL] [Abstract][Full Text] [Related]
4. Surfactant function and composition in premature infants treated with inhaled nitric oxide.
Ballard PL; Merrill JD; Truog WE; Godinez RI; Godinez MH; McDevitt TM; Ning Y; Golombek SG; Parton LA; Luan X; Cnaan A; Ballard RA
Pediatrics; 2007 Aug; 120(2):346-53. PubMed ID: 17671061
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary surfactant metabolism in infants lacking surfactant protein B.
Beers MF; Hamvas A; Moxley MA; Gonzales LW; Guttentag SH; Solarin KO; Longmore WJ; Nogee LM; Ballard PL
Am J Respir Cell Mol Biol; 2000 Mar; 22(3):380-91. PubMed ID: 10696076
[TBL] [Abstract][Full Text] [Related]
6. Very low surfactant protein C contents in newborn Belgian White and Blue calves with respiratory distress syndrome.
Danlois F; Zaltash S; Johansson J; Robertson B; Haagsman HP; van Eijk M; Beers MF; Rollin F; Ruysschaert JM; Vandenbussche G
Biochem J; 2000 Nov; 351 Pt 3(Pt 3):779-87. PubMed ID: 11042134
[TBL] [Abstract][Full Text] [Related]
7. Inherited disorders of neonatal lung diseases.
Yurdakök M
Turk J Pediatr; 2004; 46(2):105-14. PubMed ID: 15214737
[TBL] [Abstract][Full Text] [Related]
8. Pump administration of exogenous surfactant: effects on oxygenation, heart rate, and chest wall movement of premature infants.
Sitler CG; Turnage CS; McFadden BE; Smith EO; Adams JM
J Perinatol; 1993; 13(3):197-200. PubMed ID: 8345382
[TBL] [Abstract][Full Text] [Related]
9. Surfactant composition and function in a primate model of infant chronic lung disease: effects of inhaled nitric oxide.
Ballard PL; Gonzales LW; Godinez RI; Godinez MH; Savani RC; McCurnin DC; Gibson LL; Yoder BA; Kerecman JD; Grubb PH; Shaul PW
Pediatr Res; 2006 Jan; 59(1):157-62. PubMed ID: 16326985
[TBL] [Abstract][Full Text] [Related]
10. Elastase activity and surfactant protein concentration in tracheal aspirates from neonates receiving synthetic surfactant.
Gerdes J; Whitsett J; Long W
J Pediatr; 1992 Feb; 120(2 Pt 2):S34-9. PubMed ID: 1735850
[TBL] [Abstract][Full Text] [Related]
11. Bronchoalveolar lavage surfactant protein a, B, and d concentrations in preterm infants ventilated for respiratory distress syndrome receiving natural and synthetic surfactants.
Beresford MW; Shaw NJ
Pediatr Res; 2003 Apr; 53(4):663-70. PubMed ID: 12612206
[TBL] [Abstract][Full Text] [Related]
12. Failure to detect surfactant protein-specific antibodies in sera of premature infants treated with survanta, a modified bovine surfactant.
Whitsett JA; Hull WM; Luse S
Pediatrics; 1991 Apr; 87(4):505-10. PubMed ID: 2011428
[TBL] [Abstract][Full Text] [Related]
13. Surfactant protein SP-B counteracts inhibition of pulmonary surfactant by serum proteins.
Friedrich W; Schmalisch G; Stevens PA; Wauer RR
Eur J Med Res; 2000 Jul; 5(7):277-82. PubMed ID: 10903187
[TBL] [Abstract][Full Text] [Related]
14. Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized, controlled trial.
Rojas MA; Lozano JM; Rojas MX; Laughon M; Bose CL; Rondon MA; Charry L; Bastidas JA; Perez LA; Rojas C; Ovalle O; Celis LA; Garcia-Harker J; Jaramillo ML;
Pediatrics; 2009 Jan; 123(1):137-42. PubMed ID: 19117872
[TBL] [Abstract][Full Text] [Related]
15. Hyaline membrane disease (HMD) therapy in Latin America: impact of exogenous surfactant administration on newborn survival, morbidity and use of resources.
Rossello JD; Hayward PE; Martell M; Del Barco M; Margotto P; Grandzoto J; Bastida J; Peña J; Villanueva D
J Perinat Med; 1997; 25(3):280-7. PubMed ID: 9288665
[TBL] [Abstract][Full Text] [Related]
16. Lipid composition greatly affects the in vitro surface activity of lung surfactant protein mimics.
Seurynck-Servoss SL; Brown NJ; Dohm MT; Wu CW; Barron AE
Colloids Surf B Biointerfaces; 2007 May; 57(1):37-55. PubMed ID: 17287113
[TBL] [Abstract][Full Text] [Related]
17. Repeat surfactant therapy for postsurfactant slump.
Katz LA; Klein JM
J Perinatol; 2006 Jul; 26(7):414-22. PubMed ID: 16724122
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary surfactant in patients with Pneumocystis pneumonia and acquired immunodeficiency syndrome.
Schmidt R; Markart P; Ruppert C; Temmesfeld B; Nass R; Lohmeyer J; Seeger W; Günther A
Crit Care Med; 2006 Sep; 34(9):2370-6. PubMed ID: 16849999
[TBL] [Abstract][Full Text] [Related]
19. Protein content and biophysical properties of tracheal aspirates form neonates with respiratory failure.
Landmann E; Gortner L; Reiss I; Weller E; Tegtmeyer FK
Klin Padiatr; 2002; 214(1):1-7. PubMed ID: 11823947
[TBL] [Abstract][Full Text] [Related]
20. Concentration dependence of a poly-leucine surfactant protein C analogue on in vitro and in vivo surfactant activity.
Almlén A; Stichtenoth G; Robertson B; Johansson J; Curstedt T
Neonatology; 2007; 92(3):194-200. PubMed ID: 17476119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
